Does Hormonal IHC have Clinical Relavance in Pituitary Adenomas?

Journal Title: Indian Journal of Pathology: Research and Practice - Year 2018, Vol 7, Issue 5

Abstract

Background: Pituitary adenoma represent the third most common primary intracranial tumor in neurosurgical practice constituting about 10% of intracranial neoplasm. In accordance to the new WHO classification pituitary adenoma is classified according to the cell of origin which is detected immunohistochemically. Some of the pituitary adenomas may show features associated with recurrence and resistance to conventional therapy. Serological and IHC correlation helps in separating these high risk adenomas. AIM: 1. to determine clinical relevance of IHC in pituitary adenomas. 2.Identification of high risk pituitary adenomas based on immunohistochemically Materials and Methods: 30 surgically resected specimens. Sections were stained for H&E and immunostained for GH, PRL, ACTH, TSH, FSH, LH. Results: Tumor mainly affected the age group between 24 to 66years. Most cases presented as non functioning macroadenomas. Based on serological and immunohistochemical profile of pituitary adenomas we found the following results: Plurihormonal adenomas-18cases (60%), Silent corticotroph adenoma-5cases (16.67%), Lactotroph adenoma in men-3cases (10%), Null cell adenoma-2cases (6.67%), Functional thyrotroph -1cases, non-functional gonadotroph -1case. Discussion: The tumors were common between age group of 41-45 yrs, incidence in men were higher. In our study most of the cases were nonfunctional and diagnosed as macroadenomas resulting in pressure effects. The need of the hour is to subtype PA of clinical relevance. With the new WHO classification histological typing , based on immune markers is essential and older classifications of adenomas based on tictorial stains are obsolete. Prognostication based on proliferation markers remains a major challenge in pituitary pathology. Hence high risk category has been identified with the aid of immune markers. Conclusion: Earlier the diagnosis of adenoma was considered sufficient for many cases.With new classification based on IHC, it is recommended to correlate the estimated hormones levels with immune markers in routine diagnosis. As this helps in identifying the high risk groups which require intensive investigations and closer follow up.

Authors and Affiliations

Nagarjun B. R.

Keywords

Related Articles

Spontaneous Bacterial Peritonitis: Diagnostic Importance of Ascitic Fluid Polymorphonuclear Cell Count, Biochemical and Microbiological Analysis

Introduction: Ascites represents the pathological collection of fluid in the peritoneal cavity. Spontaneous bacterial peritonitis is the infection of the ascitic fluid. For its diagnosis, the number of polymorphonuclear...

A Case Report on Primary Fallopian Tube Carcinoma: An Incidental Diagnosis in a Case Operated for Leiomyoma

Primary Fallopian tube carcinomas are very rare in incidence. They occur in a wide range of age group ranging from 17 to 88 years. The etiology of these tumours is unknown. Sometimes the tumour presents clinically like a...

Comparative Evaluation of Three Cytological Grading Systems for Carcinoma Breast

Background: Fine needle aspiration cytology is an important tool in the diagnosis, prognosis and management of breast carcinoma. It has been recommended that cytological grading should be included in the FNA reports to k...

Study of Cervical Cytology Smears in Patients Presenting with Leucorrhoea

Introduction: Leucorrhoea is a persistant , excessive white vaginal discharge. It is one of the major problem in gynaecological practice. Pap smear for cervico vaginal cytology examination is one of the common method for...

Blood Donor Deferral Pattern Analysis in a Tertiary Care Center: A Study of 4902 Subjects

Introduction: Blood safety is always remaining a point of concern. In blood bank all the procedures are starting with donor selection. Individuals disqualified from donating blood are known as “deferred” donors Aim: The...

Download PDF file
  • EP ID EP522698
  • DOI 10.21088/ijprp.2278.148X.7518.12
  • Views 77
  • Downloads 0

How To Cite

Nagarjun B. R. (2018). Does Hormonal IHC have Clinical Relavance in Pituitary Adenomas?. Indian Journal of Pathology: Research and Practice, 7(5), 643-645. https://europub.co.uk/articles/-A-522698